- 专利标题： MACROCYCLIC TLR7 AGONIST, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
-
申请号： US18028363申请日： 2021-09-26
-
公开(公告)号： US20240124486A1公开(公告)日： 2024-04-18
- 发明人: Guozhi TANG , Dawei MA , Mengwei HUANG , Yongfu LIU , Yingyi WANG
- 申请人： SHANGHAI VISONPHARMA CO., LTD.
- 申请人地址： CN Shanghai
- 专利权人： SHANGHAI VISONPHARMA CO., LTD.
- 当前专利权人： SHANGHAI VISONPHARMA CO., LTD.
- 当前专利权人地址： CN Shanghai
- 优先权： CN 2011035500.0 2020.09.27
- 国际申请： PCT/CN2021/120751 2021.09.26
- 进入国家日期： 2023-10-16
- 主分类号： C07D498/22
- IPC分类号： C07D498/22 ; C07D487/22 ; C07D513/22
摘要：
A macrocyclic TLR7 agonist, a preparation method therefor, a pharmaceutical composition and use thereof. The macrocyclic TLR7 agonist disclosed is as represented by formula I, has good TLR7 agonistic activity, and can be used for treating or preventing tumors or infections caused by viruses.
信息查询
